Verastem (VSTM) Long-Term Investments (2011 - 2021)
Verastem (VSTM) recorded quarterly Long-Term Investments of $6.0 million in Q2 2021, little changed quarter-over-quarter from $6.0 million in Q1 2021.
Verastem (VSTM) Long-Term Investments (2011 - 2021) Analysis & Trends
Verastem's Long-Term Investments history runs 7 years deep, the most recent figure standing at $6.0 million for Q2 2021.
- In Q2 2021, Long-Term Investments changed N/A year-over-year to $6.0 million; the TTM figure through Jun 2021 stood at $6.0 million (changed N/A YoY), while the FY2020 annual figure was $6.0 million, changed N/A from the prior year.
- Long-Term Investments was $6.0 million for Q2 2021 at Verastem, roughly flat from $6.0 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $6.0 million in Q1 2021 to a low of $6.0 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 5.99 Mn |
| Mar 31, 2021 | 6.00 Mn |
| Dec 31, 2020 | 6.00 Mn |
| Mar 31, 2015 | 4.00 Mn |
| Jun 30, 2014 | 5.76 Mn |
| Mar 31, 2014 | 8.23 Mn |
| Dec 31, 2013 | 22.34 Mn |
| Sep 30, 2013 | 30.34 Mn |
| Jun 30, 2013 | 20.56 Mn |
| Mar 31, 2013 | 17.69 Mn |
| Dec 31, 2012 | 34.94 Mn |
| Sep 30, 2012 | 50.58 Mn |
| Jun 30, 2012 | 65.60 Mn |
| Mar 31, 2012 | 68.27 Mn |
| Dec 31, 2011 | 8.99 Mn |